Investor
Avançsa
1Undisclosed—0
Startups backed by Avançsa that were acquired: 1 exit so far, with the buyer, the price where disclosed and every source.
Photo: Ronny Siegel / Wikimedia Commons, CC BY 4.0Hologic agrees to buy Barcelona breast cancer test maker Reveal Genomics
Reveal Genomics, a 2020 spin-off of Barcelona hospitals and the University of Barcelona, makes HER2DX, a genomic test that helps choose treatment for HER2-positive breast cancer. Hologic plans to sell it alongside its own Breast Cancer Index test.
Undisclosedn/aStage n/aCorporate
Latest in Avançsa
All Avançsa exitsOpen tracker →
Hologic → Reveal GenomicsUndisclosedUndisclosed